1. Deregulated MITF sumoylation: A route to melanoma. (4th July 2017) Authors: Ballotti, Robert; Bertolotto, Corine Journal: Molecular & cellular oncology Issue: Volume 4:Number 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma. (24th January 2021) Authors: Montaudié, Henri; Beranger, Guillaume Emmanuel; Reinier, Frédéric; Nottet, Nicolas; Martin, Hélène; Picard‐Gauci, Alexandra; Troin, Laura; Ballotti, Robert; Passeron, Thierry Journal: Pigment cell & melanoma research Issue: Volume 34:Number 5(2021) Page Start: 978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness. (6th March 2016) Authors: Long, Elodie; Ilie, Marius; Bence, Coraline; Butori, Catherine; Selva, Eric; Lalvée, Salomé; Bonnetaud, Christelle; Poissonnet, Gilles; Lacour, Jean‐Philippe; Bahadoran, Philippe; Brest, Patrick; Gilson, Eric; Ballotti, Robert; Hofman, Véronique; Hofman, Paul Journal: Cancer medicine Issue: Volume 5:Number 6(2016:Jun.) Page Start: 1022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma. (2nd December 2019) Authors: Malissen, Nausicaa; Macagno, Nicolas; Granjeaud, Samuel; Granier, Clémence; Moutardier, Vincent; Gaudy-Marqueste, Caroline; Habel, Nadia; Mandavit, Marion; Guillot, Bernard; Pasero, Christine; Tartour, Eric; Ballotti, Robert; Grob, Jean-Jacques; Olive, Daniel Journal: Oncoimmunology Issue: Volume 8:Number 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Identification of melanoma initiating cells: does CD271 have a future?. (June 2015) Authors: Ballotti, Robert Journal: Future oncology Issue: Volume 11:Number 11(2015) Page Start: 1587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of melanoma initiating cells: does CD271 have a future?. (June 2015) Authors: Ballotti, Robert Journal: Future oncology Issue: Volume 11:Number 11(2015) Page Start: 1587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of melanoma initiating cells: does CD271 have a future?. (June 2015) Authors: Ballotti, Robert Journal: Future oncology Issue: Volume 11:Number 11(2015) Page Start: 1587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Is it time to test biguanide metformin in the treatment of melanoma?. (26th June 2014) Authors: Cerezo, Michael; Tomic, Tijana; Ballotti, Robert; Rocchi, Stéphane Journal: Pigment cell & melanoma research Issue: Volume 28:Number 1(2015:Jan.) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Is it time to test biguanide metformin in the treatment of melanoma?. (26th June 2014) Authors: Cerezo, Michael; Tomic, Tijana; Ballotti, Robert; Rocchi, Stéphane Journal: Pigment cell & melanoma research Issue: Volume 28:Number 1(2015:Jan.) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Jean‐Paul Ortonne. (5th August 2013) Authors: Ballotti, Robert Journal: Pigment cell & melanoma research Issue: Volume 27:Number 1(2014:Jan.) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗